Oncology Meeting Resources
- 29 Oct 2016,
Korea, Republic of
The ESMO Advanced Course on Metastatic EGFR-Mutant NSCLC 2016 was designed for understanding the biology and role of EGFR and TKI’s (1st, 2nd, 3rd generation) in the management of NSCLC; understanding the development of resistance to TKI’s and the available treatment options; understanding the role of T790M in the development of resistance; understanding the utility of different diagnostic methods in identifying the resistance mechanism and understanding the importance of the multidisciplinary team and particularly the pathologist and radiologists in optimising diagnosis and selection of the most appropriate treatment options
Presentations of the ESMO Advanced Course on Metastatic EGFR-Mutant NSCLC 2016 are available according to the presenters' agreement to release them. The use of these presentations is for personal educational purposes only. ESMO thanks the authors for their generosity.